down arrow

Sun Pharma.Inds.

Part of MojoOne Strategy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,805.00
-13.6 (-0.75%)
BSENSE

Dec 05

BSE+NSE Vol: 18.14 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
14,478.31
13,851.40
12,958.84
13,675.46
13,291.39
12,652.75
11,982.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,478.31
13,851.40
12,958.84
13,675.46
13,291.39
12,652.75
11,982.90
Raw Material Cost
1,621.51
1,771.59
1,845.06
1,408.31
1,638.72
1,557.01
1,676.73
Purchase of Finished goods
1,087.79
1,047.98
1,036.73
1,238.69
875.10
997.43
982.88
(Increase) / Decrease In Stocks
273.43
-4.81
-244.60
93.54
180.38
120.99
-279.20
Employee Cost
2,764.79
2,801.66
2,488.52
2,552.28
2,477.70
2,454.62
2,299.34
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4,203.74
3,933.32
4,117.04
4,373.62
4,180.53
3,915.08
4,268.00
Total Expenditure (Excl Depreciation)
9,951.26
9,549.74
9,242.75
9,666.44
9,352.43
9,045.13
8,947.75
Operating Profit (PBDIT) excl Other Income
4,527.05
4,301.66
3,716.09
4,009.02
3,938.96
3,607.62
3,035.15
Other Income
469.92
464.46
612.87
465.62
354.00
532.55
605.94
Operating Profit (PBDIT)
4,996.97
4,766.12
4,328.96
4,474.64
4,292.96
4,140.17
3,641.09
Interest
99.86
74.80
49.14
51.51
69.17
61.54
73.57
Exceptional Items
0.00
-818.00
-361.68
-316.17
0.00
0.00
-101.64
Gross Profit (PBDT)
4,897.11
3,873.32
3,918.14
4,106.96
4,223.79
4,078.63
3,465.88
Depreciation
729.50
700.55
663.79
630.56
625.91
655.13
650.36
Profit Before Tax
4,167.61
3,172.77
3,254.35
3,476.40
3,597.88
3,423.50
2,815.52
Tax
1,030.52
870.15
1,093.71
558.86
567.21
552.25
148.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,137.09
2,302.62
2,160.64
2,917.54
3,030.67
2,871.25
2,666.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,137.09
2,302.62
2,160.64
2,917.54
3,030.67
2,871.25
2,666.59
Share in Profit of Associates
-12.14
-9.75
-6.71
-4.56
6.66
-10.74
-7.85
Minority Interest
7.00
14.24
4.05
9.60
-2.83
24.89
4.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,117.95
2,278.63
2,149.88
2,903.38
3,040.16
2,835.62
2,654.58
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
13.0
9.5
8.96
12.1
12.67
11.82
11.06
Diluted Earnings per share
13.0
9.5
9.0
12.1
12.7
11.8
11.1
Operating Profit Margin (Excl OI)
31.43%
31.2%
29.0%
29.84%
29.7%
28.8%
25.69%
Gross Profit Margin
34.0%
28.1%
30.57%
30.56%
31.84%
32.57%
29.34%
PAT Margin
21.78%
16.7%
16.86%
21.71%
22.85%
22.93%
22.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 4.53% vs 6.89% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 36.83% vs 5.99% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 5.24% vs 15.76% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 33.50% vs 52.22% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
14,478.31
2,715.00
11,763.31
433.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,478.31
2,715.00
11,763.31
433.27%
Raw Material Cost
1,621.51
937.00
684.51
73.05%
Purchase of Finished goods
1,087.79
0.00
1,087.79
(Increase) / Decrease In Stocks
273.43
136.00
137.43
101.05%
Employee Cost
2,764.79
354.00
2,410.79
681.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4,203.74
400.00
3,803.74
950.93%
Total Expenditure (Excl Depreciation)
9,951.26
1,827.00
8,124.26
444.68%
Operating Profit (PBDIT) excl Other Income
4,527.05
888.00
3,639.05
409.80%
Other Income
469.92
145.00
324.92
224.08%
Operating Profit (PBDIT)
4,996.97
1,033.00
3,963.97
383.73%
Interest
99.86
8.00
91.86
1,148.25%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
4,897.11
1,025.00
3,872.11
377.77%
Depreciation
729.50
113.00
616.50
545.58%
Profit Before Tax
4,167.61
912.00
3,255.61
356.97%
Tax
1,030.52
223.00
807.52
362.12%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3,137.09
689.00
2,448.09
355.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
3,137.09
689.00
2,448.09
355.31%
Share in Profit of Associates
-12.14
0.00
-12.14
Minority Interest
7.00
0.00
7.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,117.95
689.00
2,428.95
352.53%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.00
26.00
-13.00
-50.00%
Diluted Earnings per share
13.00
25.97
-12.97
-49.94%
Operating Profit Margin (Excl OI)
31.43%
32.71%
0.00
-1.28%
Gross Profit Margin
34.00%
37.75%
0.00
-3.75%
PAT Margin
21.78%
25.38%
0.00
-3.60%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 14,478.31 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.53% vs 6.89% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.93% vs 9.01% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3,117.95 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 36.83% vs 5.99% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 2.56% vs 27.98% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,527.05 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.24% vs 15.76% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.93% vs 23.89% in Sep 2024

Quarterly - Interest
Interest 99.86 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 33.50% vs 52.22% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 44.37% vs 40.33% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.43%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."